COMBINED POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION AND RESECTION OF CHEST TUMOR UNDER THE SAME ANESTHETIC IS APPROPRIATE BASED ON MORBIDITY AND TUMOR PATHOLOGY
- 1 June 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 159 (6) , 1833-1835
- https://doi.org/10.1016/s0022-5347(01)63169-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.Journal of Clinical Oncology, 1996
- Late relapse of testicular cancer.Journal of Clinical Oncology, 1995
- Original Articles: Testis Cancer: Complications of Post-Chemotherapy Retroperitoneal Lymph Node DissectionJournal of Urology, 1995
- Surgical salvage of chemorefractory germ cell tumors.Journal of Clinical Oncology, 1993
- Post-Chemotherapy Tumor Residuals in Patients with Advanced Nonseminomatous Testicular Cancer. Is it Necessary to Resect All Residual Masses?Journal of Urology, 1991
- The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsCancer, 1990
- Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumorsCancer, 1986
- The Importance of One-Stage Median Sternotomy and Retroperitoneal Node Dissection in Disseminated Testicular CancerThe Annals of Thoracic Surgery, 1983